TheraRadar
← Back
Data updated: Mar 29, 2026

KANCHAN HLTHCARE

RespiratoryDermatology
Specialty

KANCHAN HLTHCARE is a specialty pharmaceutical company focused on Respiratory, Dermatology.

1967
Since
5
Drugs
-
Trials
111
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LACOSAMIDE 2026-01-29
LACOSAMIDE 2026-01-21
VARENICLINE TARTRATE 2026-01-09
VARENICLINE TARTRATE 2025-12-18
Labeling
VARENICLINE TARTRATE 2025-10-29
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 50%
1 drugs
Dermatology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Dermatology, Respiratory
PHARMACIA AND UPJOHN big-pharma
Dermatology, Respiratory
LEDERLE big-pharma
Dermatology, Respiratory
MALLINCKRODT specialty
Dermatology, Respiratory
ABBOTT big-pharma
Dermatology, Respiratory